Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes

Immunity

Volumn 21, Issue 5, 2004, Pages 719-731

  Lovett Racke, Amy E ^a   Rocchini, Anne E ^a   Choy, Judy ^a   Northrop, Sara C ^a   Hussain, Rehana Z ^a   Ratts, Robert B ^a   Sikder, Devanjan ^a   Racke, Michael K ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; STAT1 PROTEIN; STAT4 PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE SILENCING; GENE TARGETING; IMMUNE SYSTEM; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE;

ANIMALS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON TYPE II; INTERLEUKIN-12; MICE; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RNA, SMALL INTERFERING; STAT1 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 8444226727     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.09.010     Document Type: Article

References (40)

1. Afkarian M., Sedy J.R., Yang J., Jacobson N.G., Cereb N., Yang S.Y., Murphy T.L., Murphy K.M. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3:2002;549-557
2. Becher B., Durell B.G., Noelle R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110:2002;493-497
3. Bettelli E., Sullivan B., Szabo S.J., Sobel R.A., Glimcher L.H., Kuchroo V.K. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200:2004;79-87
4. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gammas. J. Immunol. 140:1988;1506-1510
5. Braunstein M., Rose A.B., Holmes S.G., Allis C.D., Broach J.R. Translational silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. 7:1993;592-604
6. Chitnis T., Najafian N., Benou C., Salama A.D., Grusby M.J., Sayegh M.H., Khoury S.J. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 108:2001;739-747
7. Cho J.Y., Grigura V., Murphy T.L., Murphy K. Identification of cooperative monomeric Brachyury sites conferring T-bet responsiveness to the proximal IFN-γ promoter. Int. Immunol. 15:2003;1149-1160
8. Chu C.Q., Wittmer S., Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:2000;123-128
9. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:2003;744-748
10. Dedon P.C., Soults J.A., Allis C.D., Gorovsky M.A. A simplified formaldehyde fixation and immunoprecipitation technique for studying protein-DNA interactions. Anal. Biochem. 197:1991;83-90
11. Duong T.T., Finkelman F.D., Strejan G.H. Effect of interferon-gamma on myelin basic protein-specific T cell line proliferation in response to antigen-pulsed accessory cells. Cell. Immunol. 145:1992;311-323
12. Duong T.T., Finkelman F.D., Singh B., Strejan G.H. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53:1994;101-107
13. Ferber I.A., Brock S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:1996;5-7
14. Finotto S., De Sanctis G.T., Lehr H.A., Herz U., Buerke M., Schipp M., Bartsch B., Atreya R., Schmitt E., Galle P.R., et al. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J. Exp. Med. 193:2001;1247-1260
15. Finotto S., Neurath M.F., Glickman J.N., Qin S., Lehr H.A., Green F.H., Ackerman K., Haley K., Galle P.R., Szabo S.J., et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 295:2002;336-338
16. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., Presky D.H. The interleukin-12/interleukin-12-receptor system. role in normal and pathologic immune responses Annu. Rev. Immunol. 16:1998;495-521
17. Goverman J., Woods A., Larson L., Weiner L.P., Hood L., Zaller D.M. Transgenic mice that express myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:1993;551-560
18. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis. evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination J. Immunol. 169:2002;7104-7110
19. Hannon G.J. RNA interference. Nature. 418:2002;244-251
20. Hadidi S., Chen Z., Phillips J., Yu K., Gorczynski R.M. Antisense deoxyoligonucleotides or antibodies to murine MD-1 inhibit rejection of allogeneic and xenogeneic skin grafts in C3H mice. Transplantation. 73:2002;1771-1779
21. Heremans H., Dillen C., Groenen M., Martens E., Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice. enhancement by monoclonal antibodies against interferon-gamma Eur. J. Immunol. 26:1996;2393-2398
22. Lublin F.D., Knobler R.L., Kalman B., Goldhaber M., Marini J., Perrault M., D'Imperio C., Joseph J., Alkan S.S., Korngold R. Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity. 16:1993;267-274
23. Lugo-Villarino G., Maldonado-Lopez R., Possemato R., Penaranda C., Glimcher L.H. T-bet is required for optimal production of IFNγ and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA. 100:2003;7749-7754
24. Melanitou E., Liu E., Miao D., Yu L., Glimcher L.H., Eisenbarth G. Absence of the T-bet gene coding for the Th1-related transcription factor does not affect diabetes-associated phenotypes in Balb/c mice. Ann. N Y Acad. Sci. 1005:2003;187-191
25. Mullen A.C., High F.A., Hutchins A.S., Lee H.W., Villarino A.V., Livingston D.M., Kung A.L., Cereb N., Yao T.P., Yang S.Y., Reiner S.L. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science. 292:2001;1907-1910
26. Neurath M.F., Weigmann B., Finotto S., Glickman J., Nieuwenhuis E., Iijima H., Mizoguchi A., Mizoguchi E., Mudter J., Galle P.R., et al. The transactivation factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195:2002;1129-1143
27. Olsson T. Cytokines in neuroinflammatory disease. role of myelin autoreactive T cell production of interferon-gamma J. Neuroimmunol. 40:1992;211-218
28. Racke M.K., Bonomo A., Scott D.E., Cannella B., Levine A., Raine C.S., Shevach E.M., Rocken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1994;1961-1966
29. Racke M.K., Burnett D., Pak S.H., Albert P.S., Cannella B., Raine C.S., McFarlin D.E., Scott D.E. Retinoid treatment of experimental allergic encephalomyelitis. Il-4 production correlates with improved disease course. J. Immunol. 154:1995;450-458
30. Rengarajan J., Szabo S.J., Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today. 21:2000;479-483
31. Schlaak J.F., Barreiros A.P., Pettersson S., Schirmacher P., Meyer Zum Buschenfelde K.H., Neurath M.F. Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogate fulminant septic shock induced by S. typhimurium in mice. Scand. J. Immunol. 54:2001;396-403
32. Shi Y., Fard A., Galeo A., Hutchinson H.G., Vermani P., Dodge G.R., Hall D.J., Shaheen F., Zalewski A. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation. 90:1994;944-951
33. Shier P., Hofstra C.L., Ma X.J., Wu Y., Ngo K., Fung-Leung W.P. Tbt-1, a new T-box transcription factor induced in activated Th1 and CD8+ T cells. Immunogenetics. 51:2000;771-778
34. Siebler J., Wirtz S., Klein S., Protschka M., Blessing M., Galle P.R., Neurath M.F. A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation. Hepatology. 38:2003;1573-1580
35. Sorensen D.R., Leirdal M., Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327:2003;761-766
36. Sullivan B.M., Juedes A., Szabo S.J., von Herrath M., Glimcher L.H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA. 100:2003;15818-15823
37. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100:2000;655-669
38. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., Glimcher L.H. Distinct effects of T-bet in Th1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science. 295:2002;338-342
39. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., Ramshaw I.A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227
40. Zhang G.X., Gran B., Yu S., Li J., Siglienti I., Chen X., Kamoun M., Rostami A. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice. IL-12 responsiveness in not required in the pathogenesis of inflammatory demyelination in the central nervous system J. Immunol. 170:2003;2153-2160